Corcept Therapeutics
CORT
#2078
Rank
โ‚ฌ7.79 B
Marketcap
73,96ย โ‚ฌ
Share price
1.71%
Change (1 day)
28.56%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ0.36 Billion

According to Corcept Therapeutics 's latest financial reports the company has โ‚ฌ0.36 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.36 B10.59%
2023-12-31โ‚ฌ0.33 B-17.23%
2022-12-31โ‚ฌ0.40 B103.88%
2021-12-31โ‚ฌ0.19 B-44.91%
2020-12-31โ‚ฌ0.35 B45.44%
2019-12-31โ‚ฌ0.24 B36.3%
2018-12-31โ‚ฌ0.18 B144.36%
2017-12-31โ‚ฌ73.96 M50.96%
2016-12-31โ‚ฌ48.99 M32.49%
2015-12-31โ‚ฌ36.98 M85.49%
2014-12-31โ‚ฌ19.93 M-49.83%
2013-12-31โ‚ฌ39.73 M-43.5%
2012-12-31โ‚ฌ70.33 M130.44%
2011-12-31โ‚ฌ30.52 M65.17%
2010-12-31โ‚ฌ18.47 M10.92%
2009-12-31โ‚ฌ16.65 M27.2%
2008-12-31โ‚ฌ13.09 M10.11%
2007-12-31โ‚ฌ11.89 M65.96%
2006-12-31โ‚ฌ7.16 M-70.81%
2005-12-31โ‚ฌ24.54 M-10.97%
2004-12-31โ‚ฌ27.57 M199.84%
2003-12-31โ‚ฌ9.19 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ15.94 B 4,301.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ14.17 B 3,813.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ8.37 B 2,212.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚ฌ8.51 B 2,250.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ12.86 B 3,453.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ15.64 B 4,219.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ79.4 M-78.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ0.22 B-38.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ1.26 B 250.46%๐Ÿ‡บ๐Ÿ‡ธ USA